Called the Megane E-Tech, the hatch instantly made a splash by driving just as sharply as it looks. Its Android-based infotainment system is easily the best in its class, and it’s ...

Australia’s leading independent law firm, Corrs Chambers Westgarth, has advised Cosette Pharmaceuticals, Inc (Cosette) on its pending A$672 million acquisition of Mayne Pharma Group Limited (Mayne) ...

Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...

Bridgewater-based Cosette Pharmaceuticals, Inc., a fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of ...

The news: ASX small cap Mayne Pharma saw its shares surge more than 30% after US-based Cosette Pharmaceuticals agreed to acquire the Adelaide-based specialty pharmaceutical company. The numbers: Mayne ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Private equity-backed US pharmaceutical giant Cosette has made a $672 million cash takeover bid for women’s health and dermatology group Mayne Pharmaceuticals. The company, which last week ...

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne ...

With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading force in women’s healthcare. The New Jersey-based drugmaker agreed to ...

Mayne told shareholders that in the absence of a better offer, the board had unanimously agreed to a scheme of arrangement with ­Cosette at $7.40 a share cash, 37 per cent higher than Thursday ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire ...

US drugmaker Cosette Pharmaceuticals has entered into a definitive agreement to acquire all the outstanding shares of Australia-based Mayne Pharma (ASX: MYX) with the aim of expanding its health ...